Dhan Chand

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  

Dhan Chand
Nov 19, 2024, 20:44 | Blog
Dhan Chand: Expanding treatment options through innovative iNKT cell therapy combinations
Dhan Chand, Vice President of Research at Agenus, shared a post on LinkedIn: "Novel cell…
Nov 17, 2024, 07:39 | Blog
Dhan Chand: Collaboration and innovation in cancer treatment at SITC 2024
Dhan Chand, Vice President of Research at Agenus, posted on LinkedIn: “Curing cancer requires more than innovative…
Nov 14, 2024, 00:24 | Blog
Jennifer Buell: Thrilled to share MiNK Therapeutics' groundbreaking work at SITC 2024
Jennifer Buell, President and Chief Executive Officer at MiNK Therapeutics, shared a post on LinkedIn…
Nov 9, 2024, 14:03 | Blog
OncoInfluencers to Follow on Social Media: Dr. Dhan Chand
We’re excited to feature Dr. Dhan Chand, a leader in cancer immunology and immunotherapy, as…
Nov 9, 2024, 10:50 | Blog
Dhan Chand: Excited to share our latest research at SITC2024
Dhan Chand, Vice President of Research at Agenus, posted on LinkedIn: "Excited to share our…
Nov 8, 2024, 14:07 | Blog
Justin Stebbing: A beautiful paper by Dhan Chand - the definition of translational work
Justin Stebbing, Visiting Professor of Cancer Medicine and Oncology at Imperial College, shared on LinkedIn:…
Oct 23, 2024, 14:59 | Blog
Spotlight on Innovation: Dhan Chand, VP of Research at Agenus
Agenus shared on LinkedIn: “Meet Dhan Chand, our Vice President of Research. Dhan believes that…
Oct 22, 2024, 14:57 | Insight
Joseph Grossman: Botensilimab is effective against Tumors Poorly Responsive to Conventional Immunotherapy
Joseph Grossman, Vice President of Early Clinical Development at Agenus,  shared a post on LinkedIn: "The…
Sep 14, 2024, 09:43 | Insight
Article of the day, September 14th, suggested by the Immune Oncology Research Institute
Immune Oncology Research Institute shared a post on LinkedIn: “Article of the day! Suggest by the Immune…
Aug 10, 2024, 13:39 | Insight
Botensilimab’s effectiveness against tumours poorly responsive to conventional immunotherapy
Justin Stebbing shared a post on LinkedIn:  “Congratulations to Dhan Chand and the Agenus team…
Jun 28, 2024, 15:58 | Insight
Updates on BOT/BAL from ESMOGI24
ESMO GI 2024 is held in Munich, Germany, and online from June 26-29. Organized by…
Jun 28, 2024, 13:48 | Insight
Arndt Vogel: Neoadjuvant botensilimab + balstilimab in MSI and MSS CRC at ESMOGI24
Arndt Vogel shared on X: "Neoadjuvant botensilimab + balstilimab in MSI and MSS CRC at…
Jun 28, 2024, 13:41 | Insight
New data from the NEST clinical trial was presented at ESMOGI24 - Agenus
Agenus shared on their X page: "New data from the NEST clinical trial was presented…
Jun 16, 2024, 02:00 | Blog
Justin Stebbing: Activity of botensilimab/balstilimab in patients with metastatic colon cancer
Justin Stebbing shared a post on LinkedIn: "Really interesting paper out today am part of in…
Jun 14, 2024, 01:23 | Insight
New Paper Alert! Promising Results for MSS Colorectal Cancer Treated with Balstilimab and Botensilimab
Promising Results for MSS Colorectal Cancer Treated with Balstilimab and Botensilimab Authors: Andrea J. Bullock,…
Jun 13, 2024, 17:33 | Insight
Agenus' Phase 1 clinical trial results have been published in Nature
Agenus shared their publication on investigational immunotherapeutic agents in Nature: "Results from our Phase 1…
Apr 9, 2024, 15:56 | Blog
We’ve been energized and inspired by our time at AACR2024 - Agenus
Agenus shared a post on LinkedIn: “We’ve been energized and inspired by our time at AACR2024.…
Jan 9, 2024, 08:50 | Blog
Prominent cancer specialists and emerging leaders in the field of oncology join the Editorial Board of OncoDaily
OncoDaily welcomes world-renowned cancer specialists and emerging leaders in oncology. We are honored to have…
Nov 17, 2023, 13:59 | Insight
Revolutionizing Cancer Immunotherapy: Next-Gen CTLA-4 Targeting and Combination Therapies
Dive into the groundbreaking research published in "Oncology Immunology" (2023), where leading scientists Nils-Petter Rudqvist,…
May 24, 2023, 15:51 | Positive
A Relentless Pursuit on Behalf of Patients: The Work of Cancer Research
Every May, the American Association for Cancer Research marks National Cancer Research Month #NCRM, committed to raising awareness…
All: 20 Posts: 1 - 100
Special Coverage